SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $941,000 | -56.7% | 384,000 | -54.9% | 0.00% | -50.0% |
Q4 2014 | $2,173,000 | -44.9% | 852,100 | +54.3% | 0.00% | -50.0% |
Q3 2014 | $3,942,000 | -33.2% | 552,100 | -39.0% | 0.00% | -33.3% |
Q2 2014 | $5,901,000 | +12.1% | 905,100 | +13.7% | 0.01% | 0.0% |
Q1 2014 | $5,263,000 | +83.8% | 796,200 | +31.8% | 0.01% | +100.0% |
Q4 2013 | $2,864,000 | -4.4% | 604,300 | 0.0% | 0.00% | -25.0% |
Q3 2013 | $2,997,000 | -4.8% | 604,300 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $3,148,000 | – | 604,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |